Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Fully-Differential TPoS Resonators Based on Dual Interdigital Electrodes for Feedthrough Suppression.

Zhang Y, Bao JF, Li XY, Zhou X, Wu ZH, Zhang XS.

Micromachines (Basel). 2020 Jan 21;11(2). pii: E119. doi: 10.3390/mi11020119.

2.

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.

Xiu B, Chi Y, Liu L, Chi W, Zhang Q, Chen J, Guo R, Si J, Li L, Xue J, Shao ZM, Wu ZH, Huang S, Wu J.

Mol Cancer. 2019 Dec 19;18(1):187. doi: 10.1186/s12943-019-1115-y.

3.

Withdrawal: DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion.

Niu J, Shi Y, Tan G, Yang CH, Fan M, Pfeffer LM, Wu ZH.

J Biol Chem. 2019 Nov 22;294(47):18015. doi: 10.1074/jbc.W119.011598. No abstract available.

4.

Correction: Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression.

Wang W, Chapman NM, Zhang B, Li M, Fan M, Laribee RN, Zaidi MR, Pfeffer LM, Chi H, Wu ZH.

Cancer Res. 2019 Nov 1;79(21):5682. doi: 10.1158/0008-5472.CAN-19-2862. No abstract available.

5.

Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression.

Wang W, Chapman NM, Zhang B, Li M, Fan M, Laribee RN, Zaidi MR, Pfeffer LM, Chi H, Wu ZH.

Cancer Res. 2019 Jun 1;79(11):2909-2922. doi: 10.1158/0008-5472.CAN-18-3134. Epub 2019 Feb 8. Erratum in: Cancer Res. 2019 Nov 1;79(21):5682.

PMID:
30737234
6.

Progress of individualized chemotherapy for gastric carcinoma under the guidance of genetic testing.

Jin X, Jiang ML, Wu ZH, Fan Y.

Curr Med Chem. 2019 Feb 4. doi: 10.2174/0929867326666190204123101. [Epub ahead of print]

PMID:
30714518
7.

BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.

Sethuraman A, Brown M, Krutilina R, Wu ZH, Seagroves TN, Pfeffer LM, Fan M.

Breast Cancer Res. 2018 Oct 1;20(1):117. doi: 10.1186/s13058-018-1046-3.

8.

The conserved RNA recognition motif and C3H1 domain of the Not4 ubiquitin ligase regulate in vivo ligase function.

Chen H, Sirupangi T, Wu ZH, Johnson DL, Laribee RN.

Sci Rep. 2018 May 25;8(1):8163. doi: 10.1038/s41598-018-26576-1.

9.

Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-κB Activation.

Wang W, Zhang B, Mani AM, Wu Z, Fan Y, Li W, Wu ZH.

J Pharmacol Exp Ther. 2018 Jul;366(1):184-193. doi: 10.1124/jpet.118.249151. Epub 2018 May 7.

10.

The Electrochemical Performance of Silicon Nanoparticles in Concentrated Electrolyte.

Chang ZH, Wang JT, Wu ZH, Gao M, Wu SJ, Lu SG.

ChemSusChem. 2018 Jun 11;11(11):1787-1796. doi: 10.1002/cssc.201800480. Epub 2018 May 15.

PMID:
29673129
11.

MiR-181 family-specific behavior in different cancers: a meta-analysis view.

Pop-Bica C, Pintea S, Cojocneanu-Petric R, Del Sal G, Piazza S, Wu ZH, Alencar AJ, Lossos IS, Berindan-Neagoe I, Calin GA.

Cancer Metastasis Rev. 2018 Mar;37(1):17-32. doi: 10.1007/s10555-017-9714-9.

PMID:
29327093
12.

DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression.

Wang W, Mani AM, Wu ZH.

J Cancer Metastasis Treat. 2017;3:45-59. doi: 10.20517/2394-4722.2017.03. Epub 2017 Mar 27.

13.

SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.

Sethuraman A, Brown M, Seagroves TN, Wu ZH, Pfeffer LM, Fan M.

Breast Cancer Res. 2016 Aug 5;18(1):81. doi: 10.1186/s13058-016-0738-9.

14.

MicroRNA regulation of F-box proteins and its role in cancer.

Wu ZH, Pfeffer LM.

Semin Cancer Biol. 2016 Feb;36:80-7. doi: 10.1016/j.semcancer.2015.09.016. Epub 2015 Oct 1. Review.

15.

Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.

Niu J, Xue A, Chi Y, Xue J, Wang W, Zhao Z, Fan M, Yang CH, Shao ZM, Pfeffer LM, Wu J, Wu ZH.

Oncogene. 2016 Mar 10;35(10):1302-1313. doi: 10.1038/onc.2015.189. Epub 2015 Jun 1.

16.

TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 Ligase.

Wang W, Huang X, Xin HB, Fu M, Xue A, Wu ZH.

J Biol Chem. 2015 May 22;290(21):13372-85. doi: 10.1074/jbc.M115.643767. Epub 2015 Apr 10.

17.

MicroRNAs in cancer therapeutic response: Friend and foe.

Xue J, Niu J, Wu J, Wu ZH.

World J Clin Oncol. 2014 Oct 10;5(4):730-43. doi: 10.5306/wjco.v5.i4.730. Review.

18.

USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO.

Niu J, Shi Y, Xue J, Miao R, Huang S, Wang T, Wu J, Fu M, Wu ZH.

EMBO J. 2013 Dec 11;32(24):3206-19. doi: 10.1038/emboj.2013.247. Epub 2013 Nov 22.

19.

Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells.

Fan M, Krutilina R, Sun J, Sethuraman A, Yang CH, Wu ZH, Yue J, Pfeffer LM.

J Biol Chem. 2013 Sep 20;288(38):27480-93. doi: 10.1074/jbc.M113.491803. Epub 2013 Aug 6.

20.

When ubiquitin meets NF-κB: a trove for anti-cancer drug development.

Wu ZH, Shi Y.

Curr Pharm Des. 2013;19(18):3263-75. Review.

Supplemental Content

Loading ...
Support Center